STOCK OPTION PLAN AND STOCK-BASED COMPENSATION

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

STOCK OPTION PLAN AND STOCK-BASED COMPENSATION

NOTE 12 – STOCK OPTION PLAN AND STOCK-BASED COMPENSATION

On January 15, 2021, the Company adopted a stock option plan entitled “The 2021 Employee, Director and Consultant Stock Plan” (the “2021 Plan”) under which the Company may grant Options to Purchase Stock, Stock Awards or Stock Appreciation Rights up to 15% of the then fully diluted number of shares of the Company’s Common Stock, automatically adjusted on January 1 each year. On January 1, 2026, the 2021 Plan was reset in accordance with its stipulations. After the reset on January 1, 2026, there were 51,787,524 shares of Common Stock awards available for grant.

Under the terms of the 2021 Plan, the Board of Directors shall specify the exercise price and vesting period of each stock option on the grant date. Vesting of the options is typically immediate and the options typically expire in five years. Stock Awards, which are fully and immediately vested upon issuance, may be directly issued under the Plan (without any intervening options).

Shares Awarded and Issued 2021 Plan:

As at June 30, 2026, there were 10,062,844 shares issued valued at a fair historic market value of $809,407 at the time of award and at June 30, 2025, there were 8,819,753 shares issued valued at a fair historic market value of $702,084 at the time of award.

The following table summarizes the Company’s granted and issued stock awards in the six months ended June 30, 2026, and 2025:

Issuances under the 2021 Stock Plan in the period January 1 and June 30, 2025

Date			# Shares				Amount				Price/Share				Type		Notice
1/01/2025				5,520,101			$	481,057			$	0.087
1/06/2025	*			634,921				43,045				0.067			stipend		affiliate
1/06/2025				164,731				11,037				0.067			stipend
1/06/2025	*			1,315,780				88,031				0.067			bonus		affiliate
1/06/2025				1,134,220				78,914				0.067			bonus
5/12/2026				156,255				21,876				0.140			stipend		affiliates
5/12/2026				110,384				15,454				0.140			stipend
6/30/2025				9,036,392			$	739,889			$	0.081

There has been no issuance under the 2021 Stock Plan in the period January 1 and June 30, 2026

Date

# Shares

Amount

Price/Share

Type

Notice

6/30/2026

10,062,844

$

809,407

$

0.080

Shares awarded, but not yet issued, under the 2021 Stock Plan at June 30, 2026:

Date

# Shares

Amount

Price/Share

Type

Notice

1/01/2026

*

1,081,875

$

82,006

$

0.076

stipend

affiliate

1/01/2026

150,250

11,389

0.076

stipend

1/30/2026

*

†

30,000,000

1,278,600

0.043

performance grant

affiliate

3/31/2026

254,240

11,415

0.045

stipend

6/30/2026

300,568

7,815

0.026

stipend

6/30/2026

31,786,933

$

1,391,225

$

0.044

*	The shares will be issued as shares of Preferred Stock, but are for comparison purposes expressed as Common share equivalents in this table.
†	The Board of Directors awarded the CEO 6,000,000 Preferred Shares, a 1:5 conversion, as a performance grant in recognition for his role in advancing capital funding initiatives and establishing a distribution agreement for dietary supplements.

	The Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to Rule 701 of the Securities Act.

For the six months ended June 30, 2026, the Company recorded stock-based compensation expense of $1,297,830 ($1,278,600 to affiliates) in connection with share-based payment awards. For the six months ended June 30, 2025, the Company recorded stock-based compensation expense of $69,061 ($27,795 to affiliates) in connection with share-based payment awards.

Stock options granted and vested 2021 Plan:

As at June 30, 2026 and 2025, there was no unrecognized compensation expense related to non-vested stock option awards.

As at June 30, 2026, the Company has 20,000,591 options or stock awards available for grant under the 2021 Plan.